The availability of tools for probing the genome and proteome more efficiently has allowed for the rapid discovery of novel genes and peptides that play important, previously uncharacterized roles in neuroendocrine regulation. In this review, the role of a class of neuropeptides containing the C-terminal Arg-Phe-NH 2 (RFamide) in regulating the reproductive axis will be highlighted. Neuropeptides containing the C-terminal PheMet-Arg-Phe-NH 2 (FMRFamide) were first identified as cardioregulatory elements in the bi-valve mollusk Macrocallista nimbosa. During the past two decades, numerous studies have shown the presence of structurally similar peptides sharing the RFamide motif across taxa. In vertebrates, RFamide peptides have pronounced influences on opiatergic regulation and neuroendocrine function. Two key peptides in this family are emerging as important regulators of the reproductive axis, kisspeptin and gonadotropin-inhibitory hormone (GnIH). Kisspeptin acts as the accelerator, directly driving gonadotropin-releasing hormone (GnRH) neurons, whereas GnIH acts as the restraint. Recent evidence suggests that both peptides play a role in mediating the negative feedback effects of sex steroids. This review presents the hypothesis that these peptides share complementary roles by responding to internal and external stimuli with opposing actions to precisely regulate the reproductive axis.
Individual neuropeptides containing the C-terminal ArgPhe-NH 2 (RFamide) are emerging as prominent regulators of neuroendocrine function. All RFamide peptides characterized to date are in a position to directly or indirectly act on the reproductive neuroendocrine axis. This review will focus on the role of kisspeptin and gonadotropin-inhibitory hormone (GnIH), both shown to have marked direct, but opposing actions, on the GnRH system. In contrast to the effects of these peptides on GnRH, the means by which environmental, social, and internal stimuli impinge on these peptidergic systems to regulate reproductive function remain largely unspecified. The goal of this review is to highlight the identified roles played by these RFamide peptides and propose a model whereby interactions between these systems place these neurochemicals in a position to be chief 'yin and yang' regulators of the reproductive axis.
Discovery and functional significance of RFamide peptides
Frank Beach borrowed the words of Ebbinghaus when he stated that behavioral endocrinology has a long history but a short past (Beach, 1974) . The same can be said for RFamide peptides and the regulation of neuroendocrine function. Almost 30 years ago, the cardioexcitatory neuropeptide containing the C-terminal Phe-Met-Arg-Phe-NH 2 (FMRFamide) was identified in the ganglia of the clam Macrocallista nimbosa (Price and Greenberg, 1977) . Following this discovery, antibodies to FMRFamide peptides were applied as a tool for labeling structurally similar neurochemicals across taxa. Despite these antibodies recognizing and labeling cells in the CNS in several species, the identity of these labeled peptides remained unknown. In 1983, the first vertebrate RFamide peptide, LeuPro-Leu-Arg-Phe-NH 2 (LPLRFamide), was identified in chicken (Dockray et al., 1983) . When LPLRFamide peptide was injected into rats, arterial blood pressure was grossly attenuated. Likewise, application of this peptide to rat brain stem neurons altered their firing activity (Price and Greenberg, 1977) . These data provided the first evidence for the vertebrate expression of RFamide peptides and indicated a potential neuromodulatory role in mammalian brain (Tables 1 and 2 ).
The discovery of RFamide peptides in mammalian brain
Over two decades following the discovery of an avian RFamide peptide, the first mammalian RFamide-related peptides (RFRPs) were cloned and characterized by identifying appropriate extracts for further investigation based on immunoreactivity with antibodies directed against FMRFamide peptides characterized in other species (Panula et al., 1996; Perry et al., 1997) . These two peptides, called neuropeptide FF (NPFF) and neuropeptide AF (NPAF), are highly localized to the posterior pituitary, spinal cord, hypothalamus, and medulla (Panula et al., 1996) . Intracerebroventricular injections of NPAF or NPFF reverse the analgesic actions of morphine suggesting interactions with the endogenous opioid system (Jhamandas et al., 2006; Yang et al., 1985) . It was initially suspected that NPFF might be important for vasopressin secretion, as NPFF was absent from the pituitary of Brattleboro rats, but this role has not been confirmed.
One strategy for discovering RFRPs that has proven quite effective is a reverse pharmacological approach to identifying ligands for orphan G-protein-coupled receptors (GPCRs). Orphan receptors are so named because they do not have a known ligand. By monitoring downstream responses (e.g., calcium influx) of cells expressing a targeted GPCR, one could identify putative ligands without even knowing the biological actions or cellular targets of the peptide examined. The first mammalian RFamide peptide to be identified using this strategy was named prolactin-releasing peptide (PrRP). This nomenclature was based on the fact that the GPCR used to identify PrRP was expressed solely in pituitary and peptide administration led to potent prolactin release from pituitary cells (Hinuma et al., 1998) . Since the time of its discovery, studies on the role of this peptide as a stimulator of prolactin release have been equivocal, and its role as a PrRP requires re-examination (Curlewis et al., 2002; Jarry et al., 2000) . As a result, this peptide is now more commonly referred to as RFRP-1.
RFRP-1 is also a potent stimulator of corticotrophinreleasing hormone (CRH) and, in turn, the glucocorticoids indicating a key role in mediating stress responsiveness and metabolism (Table 2) Samson et al., 2003; Seal et al., 2002) . In rats, retrograde tract tracing studies uncovered projections from RFRP-1 cells to the supraoptic nucleus (SON), with injections of the peptide mediating oxytocin release (Table 2) (Maruyama et al., 1999; Zhu and Onaka, 2003) . Finally, a role for this RFRP in feeding regulation, through interactions with the dorsomedial nucleus of the hypothalamus (DMH), has been uncovered (Table 2 ) (Lawrence et al., 2000) . The discovery of an RFamide peptide negatively regulating avian reproductive function
Following the discovery of RFRP-1, an RFamide peptide was isolated in quail brain by first probing with a competitive enzyme-linked immunosorbent assay (ELISA) using an antibody directed against the RF motif on the C-terminus. Using this approach, a novel hypothalamo-hypophysial RFamide peptide was identified that rapidly and dose-dependently inhibits gonadotropin release from cultured quail pituitaries (Tsutsui et al., 2000) . Based on these initial findings, Tsutsui and colleagues named this peptide gonadotropin-inhibiting hormone (GnIH). In avian species, GnIH neurons are found only in the paraventricular nucleus of the hypothalamus (PVN) with extensive fibers projecting rostrally to the ventral paleostriatum, lateral and medial septum, preoptic area, and caudally to the median eminence, optic tectum, and brainstem (Bentley et al., 2003; Ukena et al., 2003) . The receptor for GnIH, a novel GPCR, has recently been cloned and characterized in Japanese quail . In collaboration with Tsutsui and colleagues, we have recently established an analogous role for the mammalian homologue of GnIH in reproductive axis regulation, in addition to a role for this peptide in mediating the negative feedback effects of sex steroids (Kriegsfeld et al., 2006) . A detailed examination of GnIH in avian and mammalian reproductive axis regulation follows in the next section.
The discovery of kisspeptin as a positive regulator of mammalian reproduction
In 2001, the RFamide peptide now referred to as kisspeptin was shown to be the endogenous ligand for the orphan GPCR, GPR54 (Kotani et al., 2001; Ohtaki et al., 2001) . Interestingly, the gene encoding this peptide was discovered years earlier by a group in Hershey, PA (Lee et al., 1996; Lee and Welch, 1997) . To pay homage to another major 'discovery' in Hershey, PA, the researchers named the gene Kiss1. Because the gene was originally recognized as a tumor metastasis suppressor, the product of the Kiss1 gene was originally referred to as metastin (Lee et al., 1996; Lee and Welch, 1997) . For the sake of this review, the gene product of the Kiss1 gene will be referred to as KiSS-1 mRNA and its peptide product as kisspeptin.
A role for kisspeptin in regulating reproductive function was first identified in 2003 when individuals with hypogonadism were found to have a mutation in the GPR54 gene (de Roux et al., 2003; Seminara et al., 2003) . In humans and mice lacking GPR54, the hypothalamus fails to drive adequate secretion of the gonadotropins, while pituitary responsiveness to exogenous GnRH is unaffected. Since this initial discovery, several laboratories have systematically examined the neural pathways and cellular and molecular mechanisms by which kisspeptin regulates GnRH. These investigations have revealed a compelling role for kisspeptins in GnRH regulation that will be highlighted in this review.
GnIH: structure and function
Since the dodecapeptide GnIH (Ser-Ile-Lys-Pro-Ser-Ala-TyrLeu-Pro-Leu-Arg-Phe-NH 2 ) was identified 6 years ago by Tsutsui and colleagues (Satake et al., 2001; Tsutsui et al., 2000) , research has focused on the pathways and mechanisms by which this RFamide peptide inhibits the reproductive axis. As mentioned previously, GnIH was first discovered in birds and initial studies focused on its role in avian reproduction using quail and sparrow models. GnIH has marked and rapid suppressive effects on gonadotropin release both in vivo and in vitro (Osugi et al., 2004; Tsutsui et al., 2000) . Chronic delivery of GnIH to male quail decreases luteinizing hormone (LH) and subunit mRNA and leads to testicular apoptosis and reduced spermatogenesis . In addition to these neuroendocrine effects, central injections of GnIH rapidly suppress female sexual behavior in white-crowned sparrows, as assayed by monitoring copulation-solicitation displays in response to male song . Cell bodies for GnIH are confined to the PVN in birds, with pronounced projections to hypothalamic areas, including contacts upon GnRH somata and processes (Bentley et al., 2003; Ukena et al., 2003) as well as terminals in the median eminence (Tsutsui et al., 2000) . These findings suggest a role for GnIH at multiple levels of the hypothalamo-pituitary-gonadal (HPG) axis.
The GnIH precursor encodes three related peptides (GnIH-RP1, GnIH, and GnIH-RP2) (Osugi et al., 2004; Satake et al., 2001) , all including the Leu-Pro-Xaa-Arg-Phe-NH 2 (where Xaa = Leu or Gln). In addition, Tsutsui and colleagues demonstrated that the chicken LPLRFamide peptide identified Attenuates morphine-induced analgesia (Jhamandas et al., 2006; Perry et al., 1997; Yang et al., 1985 ) NPAF Attenuates morphine-induced analgesia (Jhamandas et al., 2006; Perry et al., 1997; Yang et al., 1985) RFRP-1 (PrRP) Prolactin, CRH, glucocorticoid, oxytocin, and feeding regulation (Fukusumi et al., 2001; Hinuma et al., 1998; Hinuma et al., 2000; Lawrence et al., 2000; Maruyama et al., 1999; Matsumoto et al., 2000; Samson et al., 2003; Yoshida et al., 2003 ) RFRP 1 and/or 3 Suppression of LH, actions on GnRH? (Kriegsfeld et al., 2006 ) Kisspeptin Stimulation of GnRH, tumor metastasis suppression Kotani et al., 2001; Ohtaki et al., 2001; Thompson et al., 2004) by Dockray et al. (1983) (and see above) is a fragment of the GnIH precursor (Dockray et al., 1983; Osugi et al., 2004; Satake et al., 2001; Tsutsui et al., 2000) . Through gene database searches, mammalian homologues similar in structure to GnIH were identified . Initially, it was thought that the mammalian gene precursor encoded three peptides, termed RFRP-1, RFRP-2, and RFRP-3. It was later determined that the mammalian RFRP gene encodes only 2 RFamide peptides, RFRP-1 and -3, and the amino acid sequence thought to encode the C-terminus of RFRP-2 was, instead, included at the N-terminus of RFRP-3 (Fukusumi et al., 2001; Fukusumi et al., 2003; Ukena et al., 2002; Ukena and Tsutsui, 2005; Yoshida et al., 2003) . NPFF and RFRP-3 are closely related, with four amino acids on the C-terminal being identical . Despite this high homology, these peptides have independent receptors , further suggesting that NPFF and the RFRP-3 are not the same mature peptide with two different names. The putative receptor for GnIH has recently been cloned and characterized as a novel GPCR that shares high homology with the human and rat RFRP receptor . The receptor binds avian GnIH and GnIH-RPs with high affinity. The GnIH receptor is expressed in pituitary, hypothalamus, and spinal cord, suggesting a neuromodulatory role of GnIH in addition to its functioning as an inhibitor of pituitary gonadotropin release. Using a novel approach to receptor autoradiography, Bentley and colleagues sought to further characterize the location of GnIH binding sites in birds . By applying a rhodaminated form of GnIH in vivo, putative binding sites were identified on chicken GnRH-II cells (cGnRH-II) and in the median eminence in close proximity to GnIH-I terminals . These data suggest that GnIH may act directly on cGnRH-II cells to mediate behavior in addition to modifying gonadotropin secretion by acting at GnRH-I terminal fibers.
RFRPs: a functional mammalian GnIH homologue?
Whereas RFamide peptides similar to GnIH have been identified in mammals (Fukusumi et al., 2003; Ukena et al., 2002; Ukena and Tsutsui, 2005; Yoshida et al., 2003) , the potential role of these peptides in mammalian reproductive function remained unspecified. As mentioned previously, a role for RFRP-1 in regulating prolactin, oxytocin, CRH, and feeding behavior has been examined (Hinuma et al., 1998; Lawrence et al., 2000; Maruyama et al., 1999; Matsumoto et al., 2000; Samson et al., 2003; Seal et al., 2002; Zhu and Onaka, 2003) , but the role of RFRPs as regulators of GnRH or gonadotropin secretion has not been explored. In collaboration with Tsutsui and colleagues, we sought to characterize the distribution and functional significance of the mammalian GnIH homologue (a precursor polypeptide encoding RFRP-1 and -3; hereafter referred to as RFRP) in rodents by investigating rats (Rattus norvegicus), mice (Mus musculus), and Syrian hamsters (Mesocricetus auratus).
We first characterized the distribution of RFRP to gain insight into its potential functional significance in mammalian brain. In all three rodent species, RFRP-ir cell bodies were concentrated in the dorsomedial nucleus of the hypothalamus (DMH) (Figs. 1 and 2) , with no other brain regions showing evidence of cell body staining (Kriegsfeld et al., 2006) . As in birds, RFRP fibers and terminal fields were omnipresent in midline brain regions that concentrate GnRH neurons and fibers (Fig. 1) ; the medial septum, diagonal band of Broca, preoptic area, and anterior hypothalamus were all major targets for GnIH. The median eminence was sparsely innervated, although terminals were present. Given this projection pattern, we examined whether or not RFRP-ir cells might project upon GnRH perikarya as a mechanism of regulation. A marked percentage of GnRH cells (> 40%) received projections from RFRP-ir fibers, suggesting the potential for direct inhibitory control (Figs. 3 and 4 ). To confirm a role for mammalian RFRP as a regulator of gonadotropin secretion in mammals, we injected the peptide intracerebroventricularly (ICV) or peripherally in hamsters to determine its effects on LH. Both routes of administration rapidly and markedly inhibit LH secretion (Kriegsfeld et al., 2006) . Analogous results have been obtained in rats (Anderson et al., 2005; Johnson et al., 2005) .
Given the pronounced inhibitory actions of RFRP in mammalian brain, we examined the possibility that this peptide participates in mediating the negative feedback effects of sex steroids. We found that RFRP-ir cells express estrogen receptor-and respond to estrogen with increased FOS expression, suggesting activation by gonadal steroids (Kriegsfeld et al., 2006) (Fig. 5) . Whether this effect is mediated by projections to GnRH cells or actions on the anterior pituitary requires further examination. In rats, RFRP inhibits GnRHstimulated LH release, suggesting actions, at least in part, on the adenohypophysis (Anderson et al., 2005) . Combined with our results indicating direct projections upon GnRH cells, these findings suggest that mammalian RFRP may mediate negative feedback effects of gonadal steroids at both the hypothalamic and pituitary levels.
To provide converging evidence that our antibody was labeling RFRP and not a related RFamide peptide, we cloned the avian precursor polypeptide in Syrian hamsters and stained hamster brains for RFRP mRNA using in situ hybridization (Kriegsfeld et al., 2006) (Fig. 6) . Cells expressing RFRP precursor mRNA were confined to the DMH and localized in a pattern identical to RFRP-ir labeling. As in other mammalian species (Fukusumi et al., 2003; Hinuma et al., 2000; Ukena et al., 2002; Ukena and Tsutsui, 2001; Yoshida et al., 2003) , the precursor peptide encoded homologues to RFRP-1 and -3. Together, these recent findings point to a previously unidentified neurochemical pathway by which sex steroids act on the brain to regulate the reproductive axis. The extensive fiber projections of GnIH throughout the brain point to an opportunity for investigating the role of this peptide in an array of motivated behaviors.
Mammalian RFRPs and avian GnIH: conclusions and caveats
Reports from our group and others suggest that mammalian RFRP has actions analogous to those of avian GnIH. RFRP-ir cells form close contacts with GnRH cells, and central and peripheral injections of RFRP markedly and rapidly inhibit LH. However, whether the inhibitory effects of RFRP are through GnRH, direct actions on the pituitary or a combination of both mechanisms requires further exploration. In our initial studies, we observed most RFRP terminal fiber labeling in the inner layer of the median eminence (Kriegsfeld et al., 2006) . Using immunohistochemical amplification strategies more recently, sparse fiber labeling in the outer layer of the median eminence was seen (Kriegsfeld, unpublished data) . Whether failure to see significant RFRP-ir terminal labeling in the median eminence of rodents is the result of the specificity of the antiserum, labeling procedures, or differences in RFRP mode of action across taxa remains to be empirically determined.
Given the widespread fiber distribution of RFRP-ir cells, it would be prudent to confirm that all cell bodies for these peptides originate in the DMH. It is possible that other regions of the brain produce RFRPs that get rapidly released or transported down axons, thereby limiting cell body labeling via immunohistochemistry. In situ hybridization for RFRP precursor mRNA labels cells confined to the DMH (Kriegsfeld et al., 2006) , suggesting that this possibility is unlikely. However, injections of anterograde tracer into the DMH, combined with double-label immunohistochemistry for RFRP peptide, would allow verification of this conjecture.
As in birds, RFRP-ir fibers contact an impressive percentage of GnRH cells (Kriegsfeld et al., 2006) . These findings suggest direct suppressive actions on GnRH production and/or release by mammalian RFRP. If RFRP acts, at least in part, on GnRH cells, its administration should lead to the suppression of both LH and FSH. To date, the role of mammalian RFRPs in FSH regulation has not been examined. Likewise, further work using mammalian GnRH cells lines, tissue culture preparations, and electrophysiological studies is necessary to begin to clarify the effects of RFRP on the mammalian GnRH system. Although research on avian GnIH and mammalian RFRP is in its relative infancy, these peptides are emerging as important regulators of the reproductive axis, underscoring the importance or further investigations into the neural, cellular, and molecular mechanisms by which these peptides act.
Kisspeptin (metastin): structure and function
As mentioned previously, a role for kisspeptin as a regulator of the reproductive axis was uncovered when hypogonadotropic hypogonadism was shown to be associated with a mutation of the GPR54 receptor in humans and other animals (de Roux et al., 2003; Seminara et al., 2003) . The GPR54 receptor shares high homology with galanin receptors, although residues essential for high-affinity galanin binding are lacking (Kaiser and Kuohung, 2005) . Despite this homology, this receptor does not respond to galanin or galanin-like peptide administration. Instead, the GPR54 receptor is selective for kisspeptin (Clements et al., 2001; Kotani et al., 2001; Muir et al., 2001; Ohtaki et al., 2001 ).
Kisspeptin: a potent stimulator of the reproductive axis
Kisspeptin administration leads to marked, dose-dependent increases in LH and FSH across species Kaiser and Kuohung, 2005; Navarro et al., 2004; Navarro et al., 2005; Shahab et al., 2005; Thompson et al., 2004) , including humans (Dhillo et al., 2005) . The effects of kisspeptin are principally mediated through its actions on the GnRH system; administration of kisspeptin leads to immediate early gene expression (i.e., FOS) in GnRH cells (Irwig et al., 2004; Matsui et al., 2004) . Additionally, kisspeptin-induced gonadotropin secretion is blocked across species by the GnRH receptor antagonist acyline Irwig et al., 2004; Shahab et al., 2005) . In hypothalamic explants, kisspeptin increases GnRH cell firing and stimulates the release of GnRH (Han et al., 2005; Thompson et al., 2004) . Application of tetrodotoxin to suppress sodium-dependent action potentials does not affect this response, suggesting direct effects on GnRH cells (Han et al., 2005) . Consistent with a direct action of kisspeptin on GnRH cells, a large proportion of GnRH cells coexpress GPR54 mRNA in mice and rats (Han et al., 2005; Irwig et al., 2004; Messager et al., 2005) .
In addition to direct actions on GnRH neurons, kisspeptin may also act on pituitary gonadotrophs; kisspeptin can induce LH secretion in pituitary explants maintained in culture (Navarro et al., 2005) . Given that acyline treatment blocks the effects of kisspeptin on gonadotropin secretion in vivo, kisspeptin is unlikely to act directly on the pituitary as its principal mechanism of action (Matsui et al., 2004) . Although findings on kisspeptin influences on pituitary function are equivocal, the GPR54 receptor is, in fact, expressed in pituitary (Kotani et al., 2001; Muir et al., 2001) . Whether kisspeptin regulates pituitary hormones other than the gonadotropins or whether GPR54 binds ligands other than kisspeptin requires further study.
Kisspeptin expression and functional implications
Kisspeptin cell bodies identified by in situ hybridization are concentrated in the anteroventral-periventricular nucleus (AVPV) and arcuate nucleus (Arc), with scattered cells in the periventricular and anterodorsal preoptic nuclei (Gottsch et al., Fig. 4 . As in hamsters, RFRP-ir fibers target GnRH cells in rats (A) and mice (B). Note how RFRP fibers 'track' the GnRH fiber following it to the cell body, with several presumptive boutons along the path. For visibility, images are shown as GnRH (red) alone, RFRP fibers (green) alone, followed by their respective overlays. Images were taken at 1000× at the light level (adapted from Kriegsfeld et al., 2006) . (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) 2004; Smith et al., 2006; Smith et al., 2005b) . The availability of satisfactory antibodies against kisspeptin has precluded the ability to trace projections from kisspeptin cells (c.f., Brailoiu et al., 2005; Kinoshita et al., 2005) . In reports of kisspeptin peptide expression, immunohistochemical labeling does not overlap with that of KiSS-1 mRNA expression patterns. Whereas KiSS-1 expression occurs in the Arc and AVPV, cell bodies expressing kisspeptin peptide are typically seen in the DMH with some reports of labeling in the Arc. Because several amino acids on the C-terminus of RFamide peptides are often identical, crossreactivity among antiserums with related RFamide peptides is likely. RFRP-1 and RFRP-3 stain robustly in the DMH with marked fiber projections in the Arc nucleus (Fukusumi et al., 2001; Hinuma et al., 2000; Ukena et al., 2002; Ukena and Tsutsui, 2001; Yano et al., 2003; Yoshida et al., 2003) , suggesting that previous kisspeptin antibodies may cross-react with these related RFRPs.
As with mammalian RFRP, kisspeptin may mediate the negative feedback effects of sex steroids. Kisspeptin cells colocalize sex steroid receptors, making them a direct target for sex steroid actions (Smith et al., 2005a,b) . In the Arc, castration/ replacement has predictable effects; kisspeptin mRNA is increased following castration and decreased following sex steroid replacement (Smith et al., 2005a,b) . The opposite pattern is seen in the AVPV following the same manipulations. These findings suggest a possible role of the Arc nucleus in mediating negative feedback. The response of kisspeptin cells in the AVPV to castration and steroid replacement is incompatible with a role in sex steroid negative feedback, but consistent with a role in positive feedback effects. Further experiments are necessary to tease apart the role of both cell populations in regulating reproductive function. The availability of specific antibodies to allow tracing work to progress will provide important insight into the contribution of each kisspeptin cell population to GnRH function.
Integration and dual control by kisspeptin/GnIH: a working model Kisspeptin and GnIH act as pronounced opposing regulators of the reproductive axis, and the potential exists for these peptides to work in harmony to achieve precise control over reproductive function (Fig. 7) . The internal milieu and external environments likely impinge on both systems to Fig. 5 . RFRP-ir cells are activated by sex steroid exposure. We pursued the role of mammalian RFRP in modulating estrogen negative feedback because of the importance of this process in regulation of ovulation and the coordination of receptivity. Ovariectomized hamsters were injected with either estradiol (C, D) or oil vehicle (A, B) and sacrificed 3 h following injection. The percentage of double-labeled RFRP and FOS neurons were counted (see Kriegsfeld et al., 2006) . In oiltreated controls, few RFRP cells expressed FOS (A, B), while robust expression of FOS was evident in RFRP cells following estradiol treatment (C, D) (adapted from Kriegsfeld et al., 2006) . allow stimulation of kisspeptin and inhibition of GnIH when conditions are favorable for reproduction and the opposite response when conditions are unfavorable. By applying this dual level of control, precision can be gained beyond that which can be achieved by either system acting alone.
In a recent insightful review, Steiner and colleagues propose that the kisspeptin system acts as an integration point for GnRH secretagogues (e.g., glutamate and vasopressin) and metabolic stimuli (e.g., leptin and glucocorticoids) (Dungan et al., 2006) . The potential exists for GnIH to integrate inhibitory signals (e.g., GABA and opiates) to regulate the negative arm of control. It also remains possible that kisspeptin and GnIH respond to both excitatory and inhibitory signals with appropriate actions, summate the contribution of each, and then produce the appropriate response. By each system responding to both positive and negative stimuli in addition to cross-talk between the systems, a more accurate depiction of current conditions can be relayed to the GnRH system for final integration and analysis (Fig. 7) . In summary, both of these RFamide peptides are in a position to play important, previously unspecified roles in reproductive function. Enormous potential exists for exploring the relationship between these peptides and their interactions with other known regulators of the reproductive axis.
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